Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,386.50
-10.50 (-0.75%)
Apr 29, 2026, 8:44 AM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.01 billion as of April 28, 2026. Its market cap has decreased by -26.85% in one year.
Market Cap
3.01B
Enterprise Value
4.03B
Revenue
2.49B
Ranking
n/a
PE Ratio
10.39
Stock Price
1,386.50
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.01B, an increase of 541.73%. That is a compound annual growth rate of 9.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 1.71B |
| Allergy Therapeutics | 690.25M |
| Haleon | 31.17B |
| Shield Therapeutics | 94.56M |
| Venture Life Group | 71.39M |
| ECO Animal Health Group | 63.69M |
| Provexis | 22.05M |
| Chill Brands Group | 2.22M |